| |
| |
|
| Insider
Information: |
Henderson Jane |
| Relationship: |
Officer |
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
331,871 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$11,210,340 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
331,871 |
|
|
| Total
Value |
$11,210,340 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Panacos Pharma Inc |
PANC |
Chief Financial Office... |
2008-04-30 |
125,000 |
2008-01-03 |
0 |
Premium* |
|
|
Voyager Therapeutics, Inc. |
VYGR |
Sr. V.P. & CFO, Corp. ... |
2018-03-23 |
0 |
2018-03-16 |
0 |
Premium* |
|
|
Iveric Bio Inc |
ISEE |
Director |
2023-07-11 |
0 |
2022-05-11 |
0 |
Premium* |
|
|
Akero Therapeutics, Inc. |
AKRO |
|
2023-06-16 |
0 |
2023-06-16 |
0 |
Premium* |
|
|
Apogee Therapeutics, Inc. |
APGE |
Officer |
2023-07-13 |
206,871 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APGE |
Apogee Therapeutics, Inc. |
Chief Financial OfficerOfficer |
• – – |
2023-07-13 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
206,871 |
|
- |
|
| APGE |
Apogee Therapeutics, Inc. |
Chief Financial OfficerOfficer |
• – – |
2023-07-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
188,286 |
|
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2023-07-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(22,088) |
0 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
|
– • – |
2023-06-16 |
4 |
S |
$53.79 |
$2,166,685 |
D/D |
(40,000) |
0 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
|
– • – |
2023-06-16 |
4 |
OE |
$7.01 |
$280,400 |
D/D |
40,000 |
40,000 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2023-05-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,588 |
22,088 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2022-05-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Sr. V.P. & CFO, Corp. Dev. |
• – – |
2018-03-23 |
4 |
S |
$20.52 |
$229,824 |
D/D |
(11,200) |
0 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Sr. V.P. & CFO, Corp. Dev. |
• – – |
2018-03-23 |
4 |
OE |
$11.97 |
$134,064 |
D/D |
11,200 |
11,200 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Sr. V.P. & CFO, Corp. Dev. |
• – – |
2018-03-22 |
4 |
S |
$21.07 |
$419,293 |
D/D |
(19,900) |
0 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Sr. V.P. & CFO, Corp. Dev. |
• – – |
2018-03-22 |
4 |
OE |
$11.97 |
$238,203 |
D/D |
19,900 |
19,900 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
CFO & SVP, Corp. Dev. |
• – – |
2018-03-19 |
4 |
S |
$21.76 |
$41,344 |
D/D |
(1,900) |
0 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
CFO & SVP, Corp. Dev. |
• – – |
2018-03-19 |
4 |
OE |
$11.97 |
$22,743 |
D/D |
1,900 |
1,900 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
CFO & SVP, Corp. Dev. |
• – – |
2018-03-16 |
4 |
S |
$22.15 |
$341,464 |
D/D |
(15,416) |
0 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
CFO & SVP, Corp. Dev. |
• – – |
2018-03-16 |
4 |
OE |
$11.97 |
$184,530 |
D/D |
15,416 |
15,416 |
0 |
- |
|
| PANC |
Panacos Pharma Inc |
Chief Financial Officer & CBO |
• – – |
2008-04-30 |
4/A |
B |
$0.47 |
$23,535 |
D/D |
50,000 |
125,000 |
2.74 |
- |
|
| PANC |
Panacos Pharma Inc |
Chief Financial Officer & CBO |
• – – |
2008-04-30 |
4 |
A |
$0.47 |
$23,535 |
D/D |
50,000 |
125,000 |
0 |
- |
|
| PANC |
Panacos Pharma Inc |
Chief Financial Officer, CBO |
• – – |
2008-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
75,000 |
0 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
